快速访问
文章信息
参考文献
[1]ADRADA BEATRIZ E et al. Triple-Negative Breast Cancer: Histopathologic Features, Genomics, and Treatment. [J]. Radiographics : a review publication of the Radiological Society of North America, Inc, 2023, 43(10) : e230034-e230034.
[2]杨硕, 黄芊, 朱中博, 等.基于“四气五味”阐述阳和汤与乳腺癌方证对应关系 [J]．辽宁中医杂志, 2019, 46(8): 1626-1627.
[3]陶瑞萍, 李钧烈.李钧烈基于“景岳痰病学说”论治乳腺癌经验探析 [J].浙江中医杂志, 2024, 59(9): 765-766.
[4]GAOJIAN HE et al. Preliminary investigation on the mechanism of baicalein regulating the effects of Nischarin on invasion and apoptosis of human breast cancer cells MCF-7 through Wnt3α/β-catenin pathway [J]. International Immunopharmacology, 2024, 143(P1): 113262-113262.
[5]YAN WAN-JUN et al. Latest research progress in the correlation between baicalein and breast cancer invasion and metastasis. [J]. Molecular and clinical oncology, 2016, 4(4): 472-476.
[6]LI XIANG et al. Network pharmacology approaches for research of Traditional Chinese Medicines. [J]. Chinese journal of natural medicines, 2023, 21(5): 323-332.
[7]YIYAN ZHAI et al. Network pharmacology: a crucial approach in traditional Chinese medicine research [J]. Chinese Medicine, 2025, 20(1): 8-8.
[8]2020年全球癌症最新数据解读 [J].中国肿瘤临床与康复, 2021, 28(3): 301.
[9]LI C-J, TZENG Y-D T, CHIU Y-H, et al. Pathogenesis and Potential Therapeutic Targets for Triple-Negative Breast Cancer [J]. Cancers, 2021, 13(12).
[10]YANG X, LI F, SHI Y, et al. Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer [J]. Acta Biochimica et Biophysica Sinica, 2024, 56(5): 763-75.
[11]叶丽红, 顾勤.周仲瑛教授的肿瘤观 [J].中国中医药信息杂志, 2002(3): 63-64.
[12]姚颖, 吴承玉.中医藏象辨证法辨治三阴性乳腺癌 [J].南京中医药大学学报, 2020, 36(2): 277-280.
[13]MI SHICHAO et al. Chinese medicine formula 'Baipuhuang Keli' inhibits triple-negative breast cancer by hindering DNA damage repair via MAPK/ERK pathway. [J]. Journal of ethnopharmacology, 2022, 304: 116077-116077.
[14]HUANG TING et al. Changes of EGFR and SMC4 expressions in triple-negative breast cancer and their early diagnostic value. [J]. Gland surgery, 2021, 10(3): 1118-1124.
[15]XIAO JIAN et al. PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature. [J]. Oncotarget, 2016, 7(36): 57832-57840.
[16]YAN WANJUN et al. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro. [J]. Drug design, development and therapy, 2018, 12: 3961-3972.
[17]LI WEIWEI et al. Fucoidan inhibits epithelial-to-mesenchymal transition via regulation of the HIF-1α pathway in mammary cancer cells under hypoxia. [J]. Oncology letters, 2019, 18(1): 330-338.
[18]SRIVASTAVA NITYANAND et al. Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens [J]. Frontiers in Oncology, 2023, 13: 1199105-1199105.
[19]WANG Y et al. Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer. [J]. Climacteric : the journal of the International Menopause Society, 2022, 26(1): 1-8.
[20]BAI J, CHEN W-B, ZHANG X-Y, et al. HIF-2α regulates CD44 to promote cancer stem cell activation in triple-negative breast cancer via PI3K/AKT/mTOR signaling [J]. World Journal of Stem Cells, 2020, 12(1): 87-99.
[21]MEGHANA MANJUNATH et al. Disarib, a Specific BCL2 Inhibitor, Induces Apoptosis in Triple-Negative Breast Cancer Cells and Impedes Tumour Progression in Xenografts by Altering Mitochondria-Associated Processes. [J]. International journal of molecular sciences, 2024, 25(12): 6485-6485.
[22]LIU S, HUANG J, GAO F, YIN Z, ZHANG R. Ginsenoside RG1 augments doxorubicin-induced apoptotic cell death in MDA-MB-231 breast cancer cell lines. J Biochem Mol Toxicol. 2022; 36(1): e22945.
[23]ADINEW GETINET M et al. The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer. [J]. Cancer genomics & proteomics, 2023, 20(3): 247-272.
[24]LI SHUQIN et al. Sinigrin Impedes the Breast Cancer Cell Growth through the Inhibition of PI3K/AKT/mTOR Phosphorylation-Mediated Cell Cycle Arrest [J]. Journal of Environmental Pathology, Toxicology and Oncology, 2022, 41(3): 33-43.
[25]MANI CHINNADURAI et al. Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells. [J]. Breast cancer research : BCR, 2019, 21(1): 104.
[26]KIM JINYONG et al. Mutations of TP53 and genes related to homologous recombination repair in breast cancer with germline BRCA1/2 mutations. [J]. Human genomics, 2023, 17(1): 2-2.
[27]WU TIANQI et al. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway. [J]. International journal of oncology, 2018, 52(6): 2001-2010.
[28]ISMAIL NOOR ZAFIRAH et al. Network pharmacology, molecular docking and molecular dynamics simulation of chalcone scaffold-based compounds targeting breast cancer receptors. [J]. Journal of biomolecular structure & dynamics, 2023, 43(7): 11-16.
版权与开放获取声明
作为一本开放获取的学术期刊，所有文章均遵循 Creative Commons Attribution 4.0 International License (CC BY 4.0) 协议发布，允许用户在署名原作者的前提下自由共享与再利用内容。所有文章均可免费供读者和机构阅读、下载、引用与传播，EWA Publishing 不会通过期刊的出版发行向读者或机构收取任何费用。